Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/15/2024 | MILLENNIUM MANAGEMENT LLC | 927,368 | $7.54 M | 16.54% | 3.05% |
05/10/2024 | VANGUARD GROUP INC | 895,315 | $7.28 M | 1.57% | 2.94% |
05/10/2024 | BLACKROCK INC. | 306,624 | $2.49 M | 10.23% | 1.01% |
05/10/2024 | CREDIT SUISSE AG/ | 248,270 | $2.02 M | 0.00% | 0.82% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 195,204 | $1.59 M | 1.36% | 0.64% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 169,812 | $1.38 M | 353.49% | 0.56% |
05/15/2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 149,318 | $1.21 M | 3.27% | 0.49% |
05/15/2024 | MORGAN STANLEY | 116,327 | $945,739 | 5.26% | 0.38% |
05/09/2024 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 77,413 | $629,368 | 21.06% | 0.25% |
05/14/2024 | NORTHERN TRUST CORP | 75,389 | $612,912 | -4.60% | 0.25% |
05/10/2024 | DIMENSIONAL FUND ADVISORS LP | 72,475 | $589,222 | 0.00% | 0.24% |
05/14/2024 | QUBE RESEARCH & TECHNOLOGIES LTD | 67,662 | $550,092 | 19.80% | 0.22% |
05/07/2024 | EMPOWERED FUNDS, LLC | 64,277 | $522,572 | 7.93% | 0.21% |
05/15/2024 | GOLDMAN SACHS GROUP INC | 62,161 | $505,369 | 100.00% | 0.20% |
05/15/2024 | STATE STREET CORP | 56,526 | $459,556 | 0.00% | 0.19% |
05/16/2024 | JANE STREET GROUP, LLC | 54,822 | $445,703 | 235.78% | 0.18% |
05/15/2024 | MARSHALL WACE, LLP | 54,679 | $444,540 | 100.00% | 0.18% |
04/25/2024 | BANK OF NEW YORK MELLON CORP | 48,451 | $393,906 | -13.00% | 0.16% |
05/10/2024 | CITIGROUP INC | 36,752 | $298,794 | 149.35% | 0.12% |
05/13/2024 | HRT FINANCIAL LP | 33,593 | $273,000 | 100.00% | 0.11% |
05/13/2024 | NATIONAL BANK OF CANADA /FI/ | 33,000 | $271,590 | 35.54% | 0.11% |
05/15/2024 | POINT72 ASIA (SINGAPORE) PTE. LTD. | 25,954 | $211,006 | 100.00% | 0.09% |
05/13/2024 | BALYASNY ASSET MANAGEMENT L.P. | 21,865 | $177,762 | 100.00% | 0.07% |
05/15/2024 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 20,578 | $167,299 | 100.00% | 0.07% |
05/13/2024 | FMR LLC | 19,966 | $162,324 | -0.37% | 0.07% |
05/15/2024 | TWO SIGMA ADVISERS, LP | 18,433 | $149,860 | -23.20% | 0.06% |
05/10/2024 | Y-INTERCEPT (HONG KONG) LTD | 18,043 | $146,690 | 100.00% | 0.06% |
05/15/2024 | PRICE T ROWE ASSOCIATES INC /MD/ | 17,600 | $144,000 | 0.00% | 0.06% |
05/14/2024 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 16,177 | $132,000 | 100.00% | 0.05% |
04/10/2024 | THOMASVILLE NATIONAL BANK | 13,350 | $108,536 | 0.00% | 0.04% |
05/01/2024 | BNP PARIBAS ARBITRAGE, SNC | 12,522 | $101,804 | 10.60% | 0.04% |
05/14/2024 | SYNOVUS FINANCIAL CORP | 11,796 | $95,901 | 0.00% | 0.04% |
05/15/2024 | TWO SIGMA INVESTMENTS, LP | 10,707 | $87,048 | -57.91% | 0.04% |
05/09/2024 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 10,477 | $85,178 | 0.00% | 0.03% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 8,690 | $70,650 | -34.95% | 0.03% |
05/13/2024 | UBS GROUP AG | 7,344 | $59,707 | -22.28% | 0.02% |
05/15/2024 | CITADEL ADVISORS LLC | 7,042 | $57,251 | -42.63% | 0.02% |
05/15/2024 | CITADEL ADVISORS LLC | 6,300 | $51,219 | 687.50% | 0.02% |
05/15/2024 | CUBIST SYSTEMATIC STRATEGIES, LLC | 5,254 | $42,715 | 100.00% | 0.02% |
05/15/2024 | CITADEL ADVISORS LLC | 1,700 | $13,821 | 750.00% | 0.01% |
05/15/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 1,117 | $9,081 | 2,048.08% | 0.00% |
05/10/2024 | MCILRATH & ECK, LLC | 753 | $6,122 | 0.00% | 0.00% |
05/09/2024 | RHUMBLINE ADVISERS | 753 | $6,121 | 0.00% | 0.00% |
05/14/2024 | MACQUARIE GROUP LTD | 576 | $5 | 100.00% | 0.00% |
04/25/2024 | SIMPLEX TRADING, LLC | 228 | $1,000 | -63.58% | 0.00% |
05/10/2024 | WELLS FARGO & COMPANY/MN | 155 | $1,260 | 1.97% | 0.00% |
05/15/2024 | ROYAL BANK OF CANADA | 99 | $1,000 | -65.63% | 0.00% |
05/10/2024 | JPMORGAN CHASE & CO | 38 | $309 | 0.00% | 0.00% |
05/15/2024 | MAN GROUP PLC | 0 | $0 | -100.00% | 0.00% |
05/15/2024 | SQUAREPOINT OPS LLC | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 65 institutional investors and hedge funds held shares of XBiotech Inc.. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 927,368
VANGUARD GROUP INC: 895,315
BlackRock Inc.: 306,624
CREDIT SUISSE AG/: 248,270
GEODE CAPITAL MANAGEMENT, LLC: 195,204
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 169,812
A. 13.12% of XBiotech Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 6.00 M shares in the last 24 months. This purchase volume represents approximately $34.20 M in transactions.